On May 12 and 13, 2015, the Forum held a public workshop to discuss evidence regarding interpretive performance in breast cancer screening. Workshop presentations and discussions examined the state of the evidence, remaining gaps, and potential opportunities for advancing research and practice in the interpretation of screening mammography. Workshop participants included clinicians and researchers, as well as representatives from the Food and Drug Administration (FDA), National Cancer Institute (NCI), and patient advocacy organizations.